Specifically, in contrast to the first study, some activating KIRs, such as KIR2DS4/1D, KIR2DS1, KIR2DS2, and KIR3DS1, were less frequent in HCC patients. The gene discussed is KIR2DS4; the disease is hepatocellular carcinoma.